Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
Health Bulletin 8 / November /2021 Roshni Dhar8 Nov 2021 4:53 PM ISTHere are Top Health Stories of the day Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with ...
HC restrains 4 pharma firms from making, selling Novartis Sacubitril, Valsartan tablets Ruchika Sharma2 Nov 2021 6:09 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or...
Natco Pharma marketing partner launches generic version of Afinitor in US Ruchika Sharma2 Oct 2021 10:30 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner Breckenridge Pharmaceutical, Inc., US has...
Natco Pharma arm launches first generic alternative to Revlimid in Canada Medical Dialogues Team2 Sept 2021 4:28 PM ISTNew Delhi: Natco Pharma (Canada), a subsidiary of Natco Pharma Limited, announced the launch of PrNat-Lenalidomide Capsules, the first generic...
Natco Pharma loses patent litigation case over anti-cancer drug Ibrutinib in US Medical Dialogues Team25 Aug 2021 6:12 PM ISTNew Delhi: In a major setback, Natco Pharma has lost a legal battle with Pharmacyclics, a subsidiary of AbbVie over patent of anti-cancer drug...
Natco Pharma transfers Lenalidomide ANDA to Arrow International Ruchika Sharma4 Aug 2021 11:30 AM ISTHyderabad: Natco Pharma Limited has recently announced that the company has transferred the Lenalidomide Capsules ANDA (2.5mg, 5mg, l0mg, l5mg,...
Delhi HC restrains Natco Pharma from infringing FMC Corporation agrochemical product Medical Dialogues Team13 July 2021 5:30 PM ISTNew Delhi: In a setback to Natco Pharma, Delhi High Court has upheld an interim injunction against the drug maker filed by FMC Corporation over...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
Natco Pharma net profit declines 43 percent to Rs 53 crore in Q4 Ruchika Sharma20 Jun 2021 10:30 AM ISTNew Delhi: Drug firm Natco Pharma on Thursday said its consolidated net profit declined by 43 per cent to Rs 53 crore for the fourth quarter...
Natco Pharma marketing partner gets USFDA nod for Carfilzomib Vials ANDA Ruchika Sharma15 Jun 2021 12:00 PM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has...
Natco Pharma marketing partner gets USFDA approval for Everolimus tablets Ruchika Sharma23 May 2021 11:30 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has...
